Slowed Release of Thrombin-cleaved Factor VIII from von Willebrand Factor by a Monoclonal and a Human Antibody Is a Novel Mechanism for Factor VIII Inhibition

This publication has 29 references indexed in Scilit:

• A Mechanism for Inhibition of Factor VIII Binding to Phospholipid by von Willebrand Factor
  Published by Elsevier ,1995
• Cleavage of Factor VIII Light Chain Is Required for Maximal Generation of Factor VIIIa Activity
  Published by Elsevier ,1995
• Expression of von Willebrand factor "Normandy": an autosomal mutation that mimics hemophilia A.
  Proceedings of the National Academy of Sciences, 1991
• Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phosphatidylserine
  Blood, 1990
• Differential proteolytic activation of factor VIII-von Willebrand factor complex by thrombin.
  Proceedings of the National Academy of Sciences, 1989
• Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipid.
  Journal of Clinical Investigation, 1989
• The interaction between human blood-coagulation factor VIII and von Willebrand factor. Characterization of a high-affinity binding site on factor VIII
  Biochemical Journal, 1989
• Factor VIII binds to von Willebrand factor via its Mr-80000 light chain
  European Journal of Biochemistry, 1987
• Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity
  Biochemistry, 1986
• Structure of human factor VIII
  Nature, 1984